Aviv de Morgan

Aviv De Morgan has a diverse range of work experience in the field of bioinformatics and research. They are currently serving as the Head of Bioinformatics at 1E Therapeutics, a position they have held since July 2022. Prior to this, Aviv held the same role at Pyxis Diagnostics starting from October 2020. They also worked as a Senior computational biologist at Pyxis Diagnostics from March 2020 to October 2020. Aviv has experience as an Adjunct Lecturer at Ruppin Academic Center from September 2013 to October 2020. They were also involved in research at the Weizmann Institute of Science, serving as a Research Associate from February 2019 to March 2020 and as a Postdoctoral Research Fellow from February 2016 to March 2020. Aviv's earlier work includes educational research and development at the Branco Weiss Institute from September 2012 to January 2014 and assistant research at the Technion - Israel Institute of Technology from January 2009 to August 2011, where their research focused on stochastic models of non-random mutagenesis.

Aviv De Morgan completed their education in chronological order as follows:

From 2016 to 2020, Aviv pursued Postgraduate Research at the Weizmann Institute of Science. However, the field of study for this degree is not specified.

In 2005, Aviv earned a Doctor of Philosophy (Ph.D.) degree in Evolutionary Biology and Bioinformatics from the University of Haifa.

Between 2001 and 2003, Aviv obtained a Master of Science (M.Sc.) degree in Biological Chemistry from the Weizmann Institute of Science.

From 1998 to 2000, Aviv completed a Bachelor of Science (B.Sc.) in Biology/Biological Sciences from The Hebrew University of Jerusalem.

Lastly, from 1996 to 1998, Aviv pursued Pharmaceutical Sciences at The Hebrew University of Jerusalem. However, the degree obtained during this period is not specified.

Additionally, Aviv obtained certifications in various courses. They completed the "EMBL Course: Whole Transcriptome Data Analysis" and "EMBL training: Next-generation sequence data processing" from EMBL, but the specific dates of completion are not provided.